Safety, Tolerability and Pharmacokinetics (PKs) Investigation of GSK3186899 in Healthy Subjects

NCT03874234 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
25
Enrollment
INDUSTRY
Sponsor class

Stopped The trial was terminated early following strategic review after emergence of nonclinical data with a non-GlaxoSmithKline asset.

Conditions

Interventions

Sponsor

GlaxoSmithKline